The use of PSA testing in screening for prostate cancer (PCa) is often a subject of debate due to its lack of specificity, as elevated levels can be found in individuals without prostate cancer, leading to false alarms and subsequent patient anxiety. The gene discussed is KLK3; the disease is prostate cancer.